What kind of "agenda" by whom, for what pupose, SLOGGER?
The agenda was to put management of the company in the hands of the statutory directors and remove it from the hands of the shadow director, which seemed to be the situation at the time. Although no new director was elected to the Board, some change in the running of the company has occurred and at least one statutory director has put his name to the last quarterly update. The operations of the company appear from the last update to be directed at attempting to identify valuable deposits in the tenements rather than being directed almost solely to drilling Guchab for the purpose of producing a JORC compliant estimate of that deposit regardless of the drilling difficulties encountered. It may not be coincidence that the former CEO resigned during that period of single-minded lunacy.
There is nothing that holders can do or say at the moment. The company is in a race against cash burn. We should see the report for Q1 2015 next week.
- Forums
- ASX - By Stock
- SBR
- Update 06/03/2015
Update 06/03/2015, page-16
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.322M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.1¢ | $3.087K | 280.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 538649 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 796042 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 538649 | 0.011 |
18 | 2485923 | 0.010 |
4 | 555666 | 0.009 |
3 | 595000 | 0.008 |
1 | 200000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 796042 | 2 |
0.013 | 352727 | 2 |
0.014 | 725927 | 5 |
0.015 | 585000 | 2 |
0.018 | 447001 | 2 |
Last trade - 15.47pm 13/11/2024 (20 minute delay) ? |
Featured News
SBR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online